These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8127033)

  • 1. In pursuit of the "holy grail": allograft tolerance.
    Nickerson PW; Steurer W; Steiger J; Strom TB
    Kidney Int Suppl; 1994 Jan; 44():S40-9. PubMed ID: 8127033
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 3. The common gammac-cytokines and transplantation tolerance.
    Li X
    Cell Mol Immunol; 2004 Jun; 1(3):167-72. PubMed ID: 16219163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WOFIE hypothesis: some thoughts on an approach toward allograft tolerance.
    Calne R
    Transplant Proc; 1996 Jun; 28(3):1152. PubMed ID: 8658605
    [No Abstract]   [Full Text] [Related]  

  • 5. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation for the millennium: attaining tolerance in our time--the Holy Grail.
    Helderman JH; Goral S
    Semin Nephrol; 2000 Jan; 20(1):83-6. PubMed ID: 10651221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance to alloantigen.
    Witzke O; Barbara JA; Wood KJ
    Rev Immunogenet; 1999; 1(3):374-86. PubMed ID: 11256428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The common gammac-cytokines and transplantation tolerance.
    Vu MD; Li XC
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):267-73. PubMed ID: 15467491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival.
    Lussow AR; Fanget L; Gao L; Buelow R; Pouletty P
    Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277
    [No Abstract]   [Full Text] [Related]  

  • 11. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
    Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of donor-reactive T cells after liver transplantation-induced tolerance in mice.
    Dahmen U; Sun H; Demetris AJ; Fung J; Duquesnoy RJ; Qian S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):334-5. PubMed ID: 8438324
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathymic tolerance induction is based on suppressor cells.
    Kampinga J; Klatter F; Bartels H; Pater J; Nieuwenhuis P; Roser B; Groen H
    Transplant Proc; 1994 Apr; 26(2):725-6. PubMed ID: 8171626
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of intrathymic mixed chimerism for maintenance of skin allograft tolerance across fully allogeneic (entire major H-2 plus multiminor histocompatibility) antigen barriers in mice.
    Eto M; Nishimura Y; Kong YY; Maeda T; Nomoto K; Kumazawa J; Nomoto K
    Transplant Proc; 1994 Apr; 26(2):841-4. PubMed ID: 8171683
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts.
    Jacobson S; Kumagai-Braesch M; Tibell A; Svensson M; Flodström-Tullberg M
    Ann N Y Acad Sci; 2008 Dec; 1150():213-6. PubMed ID: 19120298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin tolerance: in search of the Holy Grail.
    Horner BM; Randolph MA; Huang CA; Butler PE
    Transpl Int; 2008 Feb; 21(2):101-12. PubMed ID: 17903184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.